NDC properties for "Epogen" (RxCUI 205912)
About this data
The tables show NDC propoerties for Epogen with the RxCUI 205912
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for Epogen (RxCUI 205912)
| BLA | BLA103234 |
|---|---|
| MMSL_CODE | BD1401 |
| RxCUI | 205912 |
| SPL_SET_ID | 1f2d0b28-9cc5-4523-80b8-637fdaf3f7a5 |
| Prescribable Synonym | EPOGEN 10,000 UNT/ML Injectable Solution |
| RXNAV_STR | Epogen 10000 UNT/ML Injectable Solution |
| RxNorm Name | epoetin alfa 10000 UNT/ML Injectable Solution [Epogen] |
| RxNorm Synonym | EPO 10000 UNT/ML Injectable Solution [Epogen] |
| RxNorm Synonym | Epogen (epoetin alfa 10,000 UNT/ML) Injectable Solution |
| RxNorm Synonym | Epogen (epoetin alfa 20,000 UNT per 2 ML) Injectable Solution |
| RxNorm Synonym | Epogen 10000 UNT/ML Injectable Solution |
| RxNorm Synonym | ERYTHROPOIETIN 10000 UNT/ML Injectable Solution [Epogen] |
| Related queries | Interactions (for RxCUI 205912) |
NDC Properties
NDC Item 55513028301
| NDC 9 | 55513-283 |
|---|---|
| NDC 10 | 55513-283-01 |
| NDC Item | 55513028301 |
| Packaging | 2 mL in 1 VIAL |
| BLA | BLA103234 |
| FDA SPL set id | 785837 |
| Labeler | Amgen Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 1994-12-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55513-283 |
NDC Item 55513028310
| NDC 9 | 55513-283 |
|---|---|
| NDC 10 | 55513-283-10 |
| NDC Item | 55513028310 |
| Packaging | 10 VIAL in 1 PACKAGE (55513-283-10) / 2 mL in 1 VIAL (55513-283-01) |
| BLA | BLA103234 |
| FDA SPL set id | 785837 |
| Labeler | Amgen Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 1994-12-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55513-283 |
NDC Item 55513028301
| NDC 9 | 55513-283 |
|---|---|
| NDC 10 | 55513-283-01 |
| NDC Item | 55513028301 |
| Packaging | 2 mL in 1 VIAL |
| BLA | BLA103234 |
| FDA SPL set id | 785837 |
| Labeler | Amgen Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 1994-12-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55513-283 |
NDC Item 55513028310
| NDC 9 | 55513-283 |
|---|---|
| NDC 10 | 55513-283-10 |
| NDC Item | 55513028310 |
| Packaging | 10 VIAL in 1 PACKAGE (55513-283-10) / 2 mL in 1 VIAL (55513-283-01) |
| BLA | BLA103234 |
| FDA SPL set id | 785837 |
| Labeler | Amgen Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 1994-12-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55513-283 |